Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma.
Tadahisa InoueItaru NaitohRena KitanoMayu IbusukiYuji KobayashiYoshio SumidaYukiomi NakadeKiyoaki ItoMasashi YonedaPublished in: Current oncology (Toronto, Ont.) (2022)
Endobiliary RFA prolonged the patency period of uncovered SEMS combined with GC therapy in patients with eCCA. Although RFA also yielded survival benefits, its effect was restricted to locally advanced tumors.